Status:

UNKNOWN

Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Covid-19

Eligibility:

All Genders

18+ years

Brief Summary

The aim of the research is to improve patient management by rapidly identifying, based on the terrain and clinical and biological characteristics, those patients likely to present a severe form of ARD...

Eligibility Criteria

Inclusion

  • Major patient (≥18 years of age)
  • Admitted in March 2020 for confirmed Covid-19 lung disease (nasopharyngeal smear or sputum with SARS-CoV-2 positive PCR).

Exclusion

  • Patient who has expressed opposition to participation in the study.
  • Mild forms of infection that do not require hospitalization,
  • Subject under safeguard of justice
  • Subject under guardianship or trusteeship

Key Trial Info

Start Date :

April 9 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 9 2021

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04362345

Start Date

April 9 2020

End Date

January 9 2021

Last Update

December 28 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service des Maladies Infectieuses et Tropicales

Strasbourg, France, 67091